
Group Health Plan Funding: Alternative Considerations For Employers
Teah Corley is the founding principal and CEO of EmployerAdvocates.
The landscape of employer-sponsored healthcare is rapidly evolving, with rising costs (registration required) driving the need for innovative funding alternatives. As a group health plan consultant for more than 20 years, I have seen many small and mid-sized employers—particularly those with fewer than 200 employees—think their only viable option is a fully insured plan through a national carrier. However, this approach often defers critical cost controls and financial advantages to the insurance companies.
The Hidden Costs Of Fully Insured Plans
In a fully insured model, employers relinquish control over cost containment and forfeit pharmaceutical rebate revenue. These rebates—paid by manufacturers to pharmacy benefit managers (PBMs) to secure approved drug list (formulary) placement—are retained by insurers rather than benefiting the employer's health plan.
Additionally, fully insured employers often lack access to transparent claims data, making it difficult to analyze cost drivers or implement strategic savings initiatives. Ultimately, cost-containment options are limited, and premium increases leave employers with little recourse beyond plan design changes or cost-shifting to employees.
Exploring Alternative Funding Models
For many employers, the prospect of self-funding can be daunting due to concerns over cash flow and risk exposure. However, alternative strategies—such as level funding and group captive models—could offer a reasonable middle ground, enabling cost control and financial flexibility without assuming the full self-insured risk.
Level funding mirrors the structure of a fully insured plan, but with a crucial distinction: When claims are lower than expected, employers can recoup surplus funds rather than losing them to an insurer. In a fully insured model, this excess funding is retained by the insurance carrier. The level-funded model provides greater financial predictability while offering the potential for cost savings.
For employers seeking even greater control, group captive funding allows employers to share risk through risk pools spread among multiple employers. Under this model, each participant self-funds claims up to a predetermined stop-loss threshold, beyond which costs are covered by a shared risk layer and, ultimately, a reinsurance policy.
This structure allows smaller businesses to leverage the benefits traditionally reserved for large self-funded employers, such as lower pharmacy spend—in my experience, employers often see a 13% to 15% reduction in drug costs when transitioning from a fully insured to a self-funded model with full rebate pass-through. This number is also consistent with what we hear from our peers across the country. Other benefits may include:
• Full transparency into claims data for strategic cost management
• Retention of pharmaceutical rebates to offset expenses
• Reduced administrative costs and ability to plug-and-play best-in-class vendors
• Greater control as self-funded employers control their own custom plan designs and implement custom cost-containment solutions
Employers also have the option of advanced funding models whereby a plan's full three-year projected liability, plus a buffer (often 15% to 25%), is underwritten and funded in advance. This three-year advanced funding is provided via a private capital raise with a capital partner that retains the risk with the employer leveraging the interest earned on a large sum over three years. This model creates a static, reliable budget and fixed monthly contribution over 36 months.
The corpus is held in a special purpose entity trust and the health plan's monthly fixed costs and claims are paid from the trust. The trust itself carries the debt at a 102% collateralization level. This advanced funding strategy can be wrapped around and co-exist with a fully insured, level-funded or self-funded model to create stability and predictability over an extended period beyond the traditional one-year policy cycle.
Making The Right Choice For Company Needs
I've noticed employers that employ 50 to 200 people are the most vulnerable to the misconception that the only option for an employer this size is to fully insure its health plan risk through an insurance carrier.
Historically, selecting a fully insured plan was the only option for employers in this size range. Captive models that allow employers to share a layer of risk at the stop-loss level have gained momentum in recent years as a mechanism for allowing smaller employers to self-fund a portion of health plan risk to gain greater control over cost containment.
Many employers operate under the misconception that self-funding exposes the plan to open-ended risk. To the contrary, self-funded plans that incorporate a layer of stop-loss insurance or a shared captive layer of risk have a known maximum liability, very similar to fully insured plans. The key difference is that self-funded plans have access to greater transparency, control and cost-containment flexibility.
When it comes to the risks that employers need to know about to make fully informed decisions, it's important for employers to fully understand the policy terms and limitations. For example, a self-funded strategy with stop-loss or a captive funding strategy will include a stop-loss insurance policy to protect the employer from upside risk. Each policy type has a maximum liability, but may also contain limitations or exclusions.
It's also important for employers to fully understand the "attachment point" or the maximum liability that the employer will be responsible for versus what liability the stop-loss or captive will assume. Reading and understanding the policy terms and exclusions to fully understand the maximum liability can help employers better mitigate risk exposure.
The Future Of Employer-Sponsored Healthcare
As healthcare costs continue to rise, employers can explore innovative funding strategies to maintain affordability and control. Level funding and captive models may present compelling alternatives that help balance risk, transparency and financial efficiency. For forward-thinking businesses, these approaches could offer a pathway to sustainable, cost-effective healthcare solutions—without sacrificing the quality of employee benefits or financial stability.
Employers may want to request a funding analysis from their broker or consultant to compare and contrast the financial implications, pros and cons of each funding model to make fully informed decisions.
The information provided here is not investment, tax, or financial advice. You should consult with a licensed professional for advice concerning your specific situation.
Forbes Business Council is the foremost growth and networking organization for business owners and leaders. Do I qualify?
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles

Associated Press
25 minutes ago
- Associated Press
5IR Funds Leads $10M Round in GreatX to Unlock Real Estate Yield Through DeFi
Dallas, TX June 30, 2025 --( )-- 5IR Funds, a venture fund backing foundational technologies of the fifth industrial revolution, including infrastructure for the tokenized economy, today announced it is leading a $10 million strategic investment in GreatX, a decentralized finance-native (DeFi) protocol built to transform real estate equity into capital-protected, yield-generating digital assets. At the intersection of real-world assets, behavioral finance, and stablecoin infrastructure, GreatX introduces a programmable liquidity layer for the $12.3 trillion of income-producing real estate currently trapped in long-term, illiquid structures. Rather than tokenizing real estate titles, GreatX mints U.S. Treasury–backed tokens that can be optionally assigned to revenue-generating hotel properties—activating yield from both cashflow and appreciation, all while preserving principal. The result: a secure, composable asset that behaves like a stablecoin but performs like a portfolio. 'We believe GreatX represents the next evolution in RWA tokenization: asset-backed, behaviorally designed, and DeFi-native from inception,' said David Carstens, Founder and General Partner at 5IR Funds. 'In a world awash with speculative real estate plays, GreatX delivers something that actually works—for both yield seekers and protocol composability. This is the kind of real-world capital stack DeFi has been waiting for.' Backed by the Patel Family Office, a 3rd-generation real estate investment and management firm based in Dallas with deep experience in owning and managing hotels globally , GreatX is launching with institutional-grade hospitality assets in the U.S. and a 10,000+ investor pipeline spanning North America, the Middle East, and Asia. 'Our goal was never just tokenization—it was transformation,' said Kim Diamond, Co-Founder of GreatX and former Managing Director at Standard & Poor's. 'We've spent our careers building real-world portfolios. With GreatX, we've architected a product that speaks the native language of DeFi, but brings the full weight of institutional real estate discipline.' The raise will accelerate GreatX's platform rollout, regulatory pathways, and token issuance. The protocol is set to launch its first tranche of asset-linked, assignable tokens by Q4 2025. Why It Matters • $380T Global Real Estate is the world's largest store of wealth—and its least liquid • $205B Stablecoins represent programmable capital with no native yield mechanism • GreatX bridges both: U.S. Treasuries + Real Estate Cashflow = Capital-Protected RWA Yield About GreatX GreatX is a DeFi-native platform unlocking real estate equity via U.S. Treasury-backed tokens that offer stable yield, capital protection, and upside exposure through optional property assignment. Built in partnership with the Patel Family Office and led by real estate and structured finance veterans, GreatX enables global investors to access institutional real estate returns—without the friction of traditional real estate ownership. More: Contact: [email protected] About 5IR Funds 5IR Funds is a venture capital fund backing the breakthrough companies and foundational technologies of the Fifth Industrial Revolution. With a $200 million target fund , 5IR makes early-stage investments in pioneering companies across artificial intelligence (AI), blockchain, quantum computing, advanced materials, and virtual reality (VR). Led by a team of experienced technologists, entrepreneurs, and intellectual property experts, 5IR provides more than capital—it delivers strategic partnership, an extensive network, and the specialized guidance needed to build defensible, market-defining businesses. More: Contact: [email protected] Contact Information: 5IR Funds Zachary Todd 972-755-5420 Contact via Email Read the full story here: 5IR Funds Leads $10M Round in GreatX to Unlock Real Estate Yield Through DeFi Press Release Distributed by


Associated Press
26 minutes ago
- Associated Press
Forrester Consulting Total Economic Impact™ (TEI) of Nasdaq Metrio™
Nasdaq Does your organization have software in place to streamline sustainability reporting processes? When it comes to sustainability reporting, the right technology can deliver more than just compliance - it can drive quantifiable business impact. Thanks to Nasdaq Metrio's one-to-many disclosure and reporting capabilities, investment in built-for-purpose sustainability software is helping organizations demonstrate clear ROI. Nasdaq Metrio customers interviewed for a 2025 commissioned Forrester Consulting Total Economic Impact™ (TEI) study reported they recovered their initial investment within the first year of implementation, seeing net benefits quickly Download the case study to dive deeper into the cost benefits of deploying a built-for-purpose sustainability data management platform. Download the Case Study Visit 3BL Media to see more multimedia and stories from Nasdaq, Inc.
Yahoo
27 minutes ago
- Yahoo
Jim Cramer on Chevron: 'The Group is Just Not in Good Shape'
Chevron Corporation (NYSE:CVX) is one of the 11 stocks that Jim Cramer recently commented on. In response to a caller's inquiry about the company, Cramer commented: 'Okay, I'll tell you how I feel about the oil business. I don't like it, but I do like the dividends. Because of the dividends, I'm willing to bless them. But if they didn't have good dividends, believe me, I wouldn't go near the group because I think that the group is just not in good shape.' An aerial view of an oil rig at sea, the sun glinting off its structure. Chevron (NYSE:CVX) is involved in integrated energy and chemical operations, including the exploration, production, processing, and transportation of oil and gas, the development of liquefied natural gas, carbon capture initiatives, refining, and the manufacturing and marketing of fuels, petrochemicals, and related products. The company returned $6.9 billion in cash to shareholders during the first quarter, including $3.0 billion paid in dividends. Chevron (NYSE:CVX) declared a quarterly dividend of $1.71 per share, which was distributed on June 10. The stock has a yield of 4.76%. Additionally, on May 28, Cramer stated: 'Okay, I think that you have to have a view on oil when you think about this one…. And I think that first, I think oil's going lower. I think it goes to the 50s. I think it's part of the president's plan to be able to reduce the inflation rate. However, it does yield 5%. I don't want to reach for yield. I never want to just say, you know what, I'll take the 5% and not worry about the common stock. You are going to wait till this stock at 136 goes to 130 before you pull the trigger and not until then.' While we acknowledge the potential of CVX as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: The Best and Worst Dow Stocks for the Next 12 Months and 10 Unstoppable Stocks That Could Double Your Money. Disclosure: None.